Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The new report, "Pharmacy Retail Market in India", elaborates the changing role of pharmacy outlets and the gradual progression it is seeing towards building an organized format. The market is sustainable and is projected towards significant growth due to the already existing varied disease profile as well as the emerging new diseases and the growing population size being affected by such diseases.
The pharmacy sector forms the second largest share in the Indian healthcare sector. The sector sources its products through institutional and non institutional sales. The institutional sales is the sale of pharmaceuticals to hospitals, nursing homes and other such health institutions that purchase bulk drugs at discounted prices that results in partial decline in profit margin of manufacturers. Whereas, non institutional sales takes place through retail stores that happen to be the only form of sales channel that reaches directly to consumers and is a major source of revenue earning for the sector.
The pharmacy sector in India is highly regulated yet the sector suffers from circulation of sub standard and counterfeit drugs which hampers the retail segment of the business. Measures are being taken by the pharmacy regulatory bodies of the country to control the menace as it hampers the revenue earning drastically. The government is also taking major initiatives to provide medicines at subsidized rates as well as engage in tele consultation services and distribution of medicines in the rural belt.
The pharmacy retail industry in India is operates majorly in the unorganized format and is currently having approximately 12 major players operating in organized format. However, most organized players are operative regionally and are far from having a pan India presence. A variety of value added services are being incorporated by the organized players to attract a larger market share and initiatives are being taken to engage customers in brand loyalty.
To sum up, the pharmacy retail is a stable market that has strong growth potential even in the future years.
Slide 1: Executive Summary
Macroeconomic Indicators
Slide 2: Economic Indicators: GDP at cost factor cost: Quarterly (2009-10- 2012-13) & Inflation rate Monthly (Aug - Sep 2012 - Dec - Jan 2013)
Slide 3: Gross fiscal deficit: Monthly (Sep-2011-Feb 2012) & Exchange Rate: Monthly (Sep 2012- Feb 2013)
Slide 4: Lending rate: Annual (2008-09-2011-12); Trade Balance: Annual (2009-10-2012-13) & FDI: Annual (2009-10-2012-13)
Introduction
Slide 5-7: Healthcare Industry Overview
Slide 8: Comparative study between Pharmacy Chain Retailing and Traditional Medical Retailing
Slide 9: Evolving role of Pharmacy Retail
Slide 10: Pharmacy Retail Store Formats
Market Overview
Slide 11: Pharmacy Retail: Market Size & Growth and Market Segmentation
Slide 12: Distribution Channel
Role of Government
Slide 13: Summary
Slide 14-15: Role of Government in Pharmacy Retail
Slide 16: Drugs & Cosmetics Act 1940
Drivers & Challenges
Slide 17: Summary
Slide 18-23: Key Drivers
Slide 24-27: Key Challenges
Industry Association
Slide 28: All India Organization of Chemists and Druggists (AIOCD)
Key Trends
Slide 29: Summary
Slide 30-35: Key Trends in Pharmacy Retail
Technology Adoption
Slide 36: Summary
Slide 37-38: Technology Adoption in Pharmacy Retail
Competitive Landscape
Slide 39: Market Competition- Porter's Five Forces Analysis
Slide 40-42: Competitive Benchmarking
Slide 43-55: Major Public Player- Corporate information, financial snapshot and summary key ratios, key business and geographic segments, business highlights and SWOT analysis
Slide 56: Major Private Companies - Summary
Slide 57-101: Major Private Players- Corporate information, ownership and shareholding structure of company, financial snapshot, key ratios, business highlights and SWOT analysis
Slide 102: Some other players in Indian market
Strategic Insights
Slide 103: Key Strategic Recommendations
Appendix
Slide 104: Appendix
Slide 105: Sources of Information
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Services |
Pages : 135 |
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Services |
Pages : 139 |
Request Sample 
Request Discount 
Inquire Before Buy
